3PC-020 预防肿瘤坏死因子α抑制剂（抗肿瘤坏死因子α）治疗患者的感染风险

{"title":"3PC-020 预防肿瘤坏死因子α抑制剂（抗肿瘤坏死因子α）治疗患者的感染风险","authors":"ZRibera Ruiz De Vergara, AI Idoate Grijalba, L. Cabia Fernández, M. De Miguel Gaztelu","doi":"10.1136/ejhpharm-2024-eahp.77","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"23 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"3PC-020 Prevention of infectious risk in patients treated with tumour necrosis factor alpha inhibitors (anti-TNFα)\",\"authors\":\"ZRibera Ruiz De Vergara, AI Idoate Grijalba, L. Cabia Fernández, M. De Miguel Gaztelu\",\"doi\":\"10.1136/ejhpharm-2024-eahp.77\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":335223,\"journal\":{\"name\":\"Section 3: Production and Compounding\",\"volume\":\"23 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 3: Production and Compounding\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2024-eahp.77\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 3: Production and Compounding","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-eahp.77","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}